PTC Therapeutics Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
51,573.60
93,753.00
170,447.00
142,110.00
79,000.00
128,081
Depreciation, Depletion & Amortization
2,396.40
2,235.00
2,876.00
3,290.00
17,682.00
26,087
Other Funds
14,568.20
21,047.00
38,535.00
44,416.00
37,828.00
60,144
Funds from Operations
34,608.90
70,471.00
129,036.00
94,603.00
23,291.00
41,850
Changes in Working Capital
12,313.20
13,197.00
4,699.00
8,963.00
13,228.00
14,209
Net Operating Cash Flow
46,922.10
57,274.00
124,337.00
103,566.00
10,063.00
27,641
Capital Expenditures
845.70
4,664.00
2,720.00
1,776.00
3,101.00
Purchase/Sale of Investments
126,982.70
140,504.00
18,091.00
106,257.00
93,381.00
Net Investing Cash Flow
127,828.50
145,168.00
20,811.00
104,481.00
13,117.00
Issuance/Reduction of Debt, Net
4,995.80
49.00
145,350.00
-
39,568.00
Net Financing Cash Flow
187,439.30
237,126.00
154,061.00
968.00
44,218.00
Net Change in Cash
12,688.70
34,334.00
8,274.00
299.00
53,471.00
Free Cash Flow
47,767.90
61,938.00
127,057.00
105,342.00
13,164.00
Deferred Taxes & Investment Tax Credit
-
-
-
199.00
199.00
-
Change in Capital Stock
192,435.10
237,175.00
8,711.00
968.00
4,650.00
Exchange Rate Effect
-
350.00
639.00
1,584.00
6,199.00
Other Uses
-
-
-
-
77,163.00
About PTC Therapeutics
View Profile
